US 11,685,727 B2
Compounds active towards nuclear receptors
Sanne Schrøder Glad, Copenhagen (DK); Ian Sarvary, Copenhagen (DK); Alex Haahr Gouliaev, Copenhagen (DK); Thomas Franch, Copenhagen (DK); Søren Jensby Nielsen, Copenhagen (DK); Luigi Piero Stasi, Copenhagen (DK); Montserrat Erra Solà, Sant Feliu de Llobregat (ES); Lorena Taboada Martínez, Sant Feliu de Llobregat (ES); Joan Taltavull Moll, Sant Feliu de Llobregat (ES); Juan Francisco Caturla Javaloyes, Sant Feliu de Llobregat (ES); and Lluís Miquel Pagès Santacana, Sant Feliu de Llobregat (ES)
Assigned to NUEVOLUTION A/S, Copenhagen (DK)
Filed by NUEVOLUTION A/S, Copenhagen (DK)
Filed on Dec. 18, 2020, as Appl. No. 17/126,182.
Claims priority of provisional application 63/064,502, filed on Aug. 12, 2020.
Claims priority of provisional application 62/951,221, filed on Dec. 20, 2019.
Prior Publication US 2021/0188807 A1, Jun. 24, 2021
Int. Cl. C07D 401/12 (2006.01); C07D 401/14 (2006.01); A61P 21/00 (2006.01); A61P 19/02 (2006.01); C07D 413/14 (2006.01)
CPC C07D 401/12 (2013.01) [A61P 19/02 (2018.01); A61P 21/00 (2018.01); C07D 401/14 (2013.01); C07D 413/14 (2013.01)] 16 Claims
 
1. A compound, stereoisomer, or salt having a structure selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry